Key stats
About CHINA ASSET MANAGEMENT (HK) CHINAAMC HANG SENG BIOTECH ETF HKD
Home page
Inception date
Mar 18, 2021
Replication method
Physical
Primary advisor
China Asset Management (Hong Kong) Ltd.
ISIN
HK0000711199
The investment objective of the Sub-Fund is to provide investment results that, before fees and expenses, closely correspond to the performance of the Hang Seng Hong Kong-Listed Biotech Index.
Classification
What's in the fund
Exposure type
Health Technology
Stock breakdown by region
Displays a symbol's price movements over previous years to identify recurring trends.